News + Resources
Keep up with the latest
Featured
Scribe Therapeutics Highlights Data Underpinning its Comprehensive Strategy Targeting Key Lipid Drivers of ASCVD at American Heart Association (AHA) Scientific Sessions 2025
November 17, 2025
Scribe Therapeutics Highlights Data Underpinning its Comprehensive Strategy Targeting Key Lipid Drivers of ASCVD at American Heart Association (AHA) Scientific Sessions 2025
November 17, 2025
Epigenetic editors are a gentler form of gene editing
February 24, 2025
The Economist
Epigenetic editors are a gentler form of gene editing
February 24, 2025
All Stories
News
Peer Review
December 21, 2023
Endpoints News
Read Now
Press Release
Peer Review
December 21, 2023
Endpoints News
Read Now
Press Release
Scribe Therapeutics Appoints Dr. Aarif Khakoo as Chief Scientific Officer and Head of Research and Development, and Dr. Maria Mirotsou as Vice President of Discovery Biology
December 20, 2023
Read Now
Press Release
Scribe Therapeutics Appoints Dr. Aarif Khakoo as Chief Scientific Officer and Head of Research and Development, and Dr. Maria Mirotsou as Vice President of Discovery Biology
December 20, 2023
Read Now
News
FDA approves CRISPR–Cas9 therapy for sickle cell disease
December 8, 2023
ASBMB Today
Read Now
Press Release
FDA approves CRISPR–Cas9 therapy for sickle cell disease
December 8, 2023
ASBMB Today
Read Now
News
A decade later, biotech’s CRISPR revolution is still going strong
October 11, 2023
Biopharma Dive
Read Now
Press Release
A decade later, biotech’s CRISPR revolution is still going strong
October 11, 2023
Biopharma Dive
Read Now